0001562180-22-005383.txt : 20220628 0001562180-22-005383.hdr.sgml : 20220628 20220628191621 ACCESSION NUMBER: 0001562180-22-005383 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220624 FILED AS OF DATE: 20220628 DATE AS OF CHANGE: 20220628 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brege Laura CENTRAL INDEX KEY: 0001365619 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40236 FILM NUMBER: 221051410 MAIL ADDRESS: STREET 1: C/O ONYX PHARMACEUTICALS, INC. STREET 2: 2100 POWELL STREET CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edgewise Therapeutics, Inc. CENTRAL INDEX KEY: 0001710072 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 821725586 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3415 COLORADO AVE. CITY: BOULDER STATE: CO ZIP: 80303 BUSINESS PHONE: 303-735-8373 MAIL ADDRESS: STREET 1: 3415 COLORADO AVE. CITY: BOULDER STATE: CO ZIP: 80303 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2022-06-24 false 0001710072 Edgewise Therapeutics, Inc. EWTX 0001365619 Brege Laura C/O EDGEWISE THERAPEUTICS, INC. 3145 COLORADO AVE BOULDER CO 80303 true false false false Stock Option (Right to Buy) 8.53 2022-06-24 4 A false 42087.00 0.00 A 2023-06-08 2032-06-24 Common Stock 42087.00 42087.00 D 100% of the Stock Options granted on June 24, 2022 will become vested on the earlier of (i) June 24, 2023 or (ii) the business day prior to the date of the 2023 annual meeting of stockholders. /s/John R. Moore Attorney-in-Fact for Laura A. Brege 2022-06-28